非血液がんの世界市場（～2026年）

• 英文タイトル：Global Non-Hematological Cancers Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY04001
• 出版社/出版日：QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、93ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料は非血液がんのグローバル市場について調査・分析したレポートです。種類別（化学療法、手術、放射線療法、その他）市場規模、用途別（病院、腫瘍治療センター、外来手術センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別非血液がんの競争状況、市場シェア
・世界の非血液がん市場：種類別市場規模 2015年-2020年（化学療法、手術、放射線療法、その他）
・世界の非血液がん市場：種類別市場規模予測 2021年-2026年（化学療法、手術、放射線療法、その他）
・世界の非血液がん市場：用途別市場規模 2015年-2020年（病院、腫瘍治療センター、外来手術センター、その他）
・世界の非血液がん市場：用途別市場規模予測 2021年-2026年（病院、腫瘍治療センター、外来手術センター、その他）
・北米の非血液がん市場分析：米国、カナダ
・ヨーロッパの非血液がん市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの非血液がん市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の非血液がん市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの非血液がん市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Novartis、Pfizer、Bristol-Myers Squibb、Johnson & Johnson、Roche、Amgen、Astellas Pharma
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Non-Hematological cancers which cover lung cancer, prostate cancer, breast cancer and others, this type of cancer are not show easily diagnosis and the treatment process is also show long that some time it lead to the death of the patient.
North America has the huge number of population suffering from cancer, according to National Cancer Institute which come under the U.S health, the statistic published in 2016 around 1,685,210 new cancer is diagnosed and 595,690 people died due to cancer. Cancer is the second important cause of death in Europe as per the WHO Regional Office for Europe in 2012, around 3.7 million new cases of cancer occur in Europe and 1.9 million death each year. Same as for Asia Pacific and the creating the awareness is also the necessary aspect to be consider.

Market Analysis and Insights: Global Non-Hematological Cancers Market
The global Non-Hematological Cancers market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Non-Hematological Cancers Scope and Market Size
Non-Hematological Cancers market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Non-Hematological Cancers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Novartis
Pfizer
Bristol-Myers Squibb
Johnson & Johnson
Roche
Amgen
Astellas Pharma
…

Market segment by Type, the product can be split into
Chemotherapy
Surgery
Radiation Therapy
Others
Market segment by Application, split into
Hospitals
Oncology Treatment Centre
Ambulatory Surgery Centers
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Non-Hematological Cancers Revenue
1.4 Market by Type
1.4.1 Global Non-Hematological Cancers Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Chemotherapy
1.4.3 Surgery
1.4.4 Radiation Therapy
1.4.5 Others
1.5 Market by Application
1.5.1 Global Non-Hematological Cancers Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Oncology Treatment Centre
1.5.4 Ambulatory Surgery Centers
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Non-Hematological Cancers Market Perspective (2015-2026)
2.2 Global Non-Hematological Cancers Growth Trends by Regions
2.2.1 Non-Hematological Cancers Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Non-Hematological Cancers Historic Market Share by Regions (2015-2020)
2.2.3 Non-Hematological Cancers Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Non-Hematological Cancers Market Growth Strategy
2.3.6 Primary Interviews with Key Non-Hematological Cancers Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Non-Hematological Cancers Players by Market Size
3.1.1 Global Top Non-Hematological Cancers Players by Revenue (2015-2020)
3.1.2 Global Non-Hematological Cancers Revenue Market Share by Players (2015-2020)
3.1.3 Global Non-Hematological Cancers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Non-Hematological Cancers Market Concentration Ratio
3.2.1 Global Non-Hematological Cancers Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Non-Hematological Cancers Revenue in 2019
3.3 Non-Hematological Cancers Key Players Head office and Area Served
3.4 Key Players Non-Hematological Cancers Product Solution and Service
3.5 Date of Enter into Non-Hematological Cancers Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Non-Hematological Cancers Historic Market Size by Type (2015-2020)
4.2 Global Non-Hematological Cancers Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Non-Hematological Cancers Market Size by Application (2015-2020)
5.2 Global Non-Hematological Cancers Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Non-Hematological Cancers Market Size (2015-2020)
6.2 Non-Hematological Cancers Key Players in North America (2019-2020)
6.3 North America Non-Hematological Cancers Market Size by Type (2015-2020)
6.4 North America Non-Hematological Cancers Market Size by Application (2015-2020)

7 Europe
7.1 Europe Non-Hematological Cancers Market Size (2015-2020)
7.2 Non-Hematological Cancers Key Players in Europe (2019-2020)
7.3 Europe Non-Hematological Cancers Market Size by Type (2015-2020)
7.4 Europe Non-Hematological Cancers Market Size by Application (2015-2020)

8 China
8.1 China Non-Hematological Cancers Market Size (2015-2020)
8.2 Non-Hematological Cancers Key Players in China (2019-2020)
8.3 China Non-Hematological Cancers Market Size by Type (2015-2020)
8.4 China Non-Hematological Cancers Market Size by Application (2015-2020)

9 Japan
9.1 Japan Non-Hematological Cancers Market Size (2015-2020)
9.2 Non-Hematological Cancers Key Players in Japan (2019-2020)
9.3 Japan Non-Hematological Cancers Market Size by Type (2015-2020)
9.4 Japan Non-Hematological Cancers Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Non-Hematological Cancers Market Size (2015-2020)
10.2 Non-Hematological Cancers Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Non-Hematological Cancers Market Size by Type (2015-2020)
10.4 Southeast Asia Non-Hematological Cancers Market Size by Application (2015-2020)

11 India
11.1 India Non-Hematological Cancers Market Size (2015-2020)
11.2 Non-Hematological Cancers Key Players in India (2019-2020)
11.3 India Non-Hematological Cancers Market Size by Type (2015-2020)
11.4 India Non-Hematological Cancers Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Non-Hematological Cancers Market Size (2015-2020)
12.2 Non-Hematological Cancers Key Players in Central & South America (2019-2020)
12.3 Central & South America Non-Hematological Cancers Market Size by Type (2015-2020)
12.4 Central & South America Non-Hematological Cancers Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Novartis
13.1.1 Novartis Company Details
13.1.2 Novartis Business Overview
13.1.3 Novartis Non-Hematological Cancers Introduction
13.1.4 Novartis Revenue in Non-Hematological Cancers Business (2015-2020))
13.1.5 Novartis Recent Development
13.2 Pfizer
13.2.1 Pfizer Company Details
13.2.2 Pfizer Business Overview
13.2.3 Pfizer Non-Hematological Cancers Introduction
13.2.4 Pfizer Revenue in Non-Hematological Cancers Business (2015-2020)
13.2.5 Pfizer Recent Development
13.3 Bristol-Myers Squibb
13.3.1 Bristol-Myers Squibb Company Details
13.3.2 Bristol-Myers Squibb Business Overview
13.3.3 Bristol-Myers Squibb Non-Hematological Cancers Introduction
13.3.4 Bristol-Myers Squibb Revenue in Non-Hematological Cancers Business (2015-2020)
13.3.5 Bristol-Myers Squibb Recent Development
13.4 Johnson & Johnson
13.4.1 Johnson & Johnson Company Details
13.4.2 Johnson & Johnson Business Overview
13.4.3 Johnson & Johnson Non-Hematological Cancers Introduction
13.4.4 Johnson & Johnson Revenue in Non-Hematological Cancers Business (2015-2020)
13.4.5 Johnson & Johnson Recent Development
13.5 Roche
13.5.1 Roche Company Details
13.5.2 Roche Business Overview
13.5.3 Roche Non-Hematological Cancers Introduction
13.5.4 Roche Revenue in Non-Hematological Cancers Business (2015-2020)
13.5.5 Roche Recent Development
13.6 Amgen
13.6.1 Amgen Company Details
13.6.2 Amgen Business Overview
13.6.3 Amgen Non-Hematological Cancers Introduction
13.6.4 Amgen Revenue in Non-Hematological Cancers Business (2015-2020)
13.6.5 Amgen Recent Development
13.7 Astellas Pharma
13.7.1 Astellas Pharma Company Details
13.7.2 Astellas Pharma Business Overview
13.7.3 Astellas Pharma Non-Hematological Cancers Introduction
13.7.4 Astellas Pharma Revenue in Non-Hematological Cancers Business (2015-2020)
13.7.5 Astellas Pharma Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Non-Hematological Cancers Key Market Segments
Table 2. Key Players Covered: Ranking by Non-Hematological Cancers Revenue
Table 3. Ranking of Global Top Non-Hematological Cancers Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Non-Hematological Cancers Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Chemotherapy
Table 6. Key Players of Surgery
Table 7. Key Players of Radiation Therapy
Table 8. Key Players of Others
Table 9. Global Non-Hematological Cancers Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Non-Hematological Cancers Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Non-Hematological Cancers Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Non-Hematological Cancers Market Share by Regions (2015-2020)
Table 13. Global Non-Hematological Cancers Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Non-Hematological Cancers Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Non-Hematological Cancers Market Growth Strategy
Table 19. Main Points Interviewed from Key Non-Hematological Cancers Players
Table 20. Global Non-Hematological Cancers Revenue by Players (2015-2020) (Million US$)
Table 21. Global Non-Hematological Cancers Market Share by Players (2015-2020)
Table 22. Global Top Non-Hematological Cancers Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-Hematological Cancers as of 2019)
Table 23. Global Non-Hematological Cancers by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Non-Hematological Cancers Product Solution and Service
Table 26. Date of Enter into Non-Hematological Cancers Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Non-Hematological Cancers Market Size by Type (2015-2020) (Million US$)
Table 29. Global Non-Hematological Cancers Market Size Share by Type (2015-2020)
Table 30. Global Non-Hematological Cancers Revenue Market Share by Type (2021-2026)
Table 31. Global Non-Hematological Cancers Market Size Share by Application (2015-2020)
Table 32. Global Non-Hematological Cancers Market Size by Application (2015-2020) (Million US$)
Table 33. Global Non-Hematological Cancers Market Size Share by Application (2021-2026)
Table 34. North America Key Players Non-Hematological Cancers Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Non-Hematological Cancers Market Share (2019-2020)
Table 36. North America Non-Hematological Cancers Market Size by Type (2015-2020) (Million US$)
Table 37. North America Non-Hematological Cancers Market Share by Type (2015-2020)
Table 38. North America Non-Hematological Cancers Market Size by Application (2015-2020) (Million US$)
Table 39. North America Non-Hematological Cancers Market Share by Application (2015-2020)
Table 40. Europe Key Players Non-Hematological Cancers Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Non-Hematological Cancers Market Share (2019-2020)
Table 42. Europe Non-Hematological Cancers Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Non-Hematological Cancers Market Share by Type (2015-2020)
Table 44. Europe Non-Hematological Cancers Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Non-Hematological Cancers Market Share by Application (2015-2020)
Table 46. China Key Players Non-Hematological Cancers Revenue (2019-2020) (Million US$)
Table 47. China Key Players Non-Hematological Cancers Market Share (2019-2020)
Table 48. China Non-Hematological Cancers Market Size by Type (2015-2020) (Million US$)
Table 49. China Non-Hematological Cancers Market Share by Type (2015-2020)
Table 50. China Non-Hematological Cancers Market Size by Application (2015-2020) (Million US$)
Table 51. China Non-Hematological Cancers Market Share by Application (2015-2020)
Table 52. Japan Key Players Non-Hematological Cancers Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Non-Hematological Cancers Market Share (2019-2020)
Table 54. Japan Non-Hematological Cancers Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Non-Hematological Cancers Market Share by Type (2015-2020)
Table 56. Japan Non-Hematological Cancers Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Non-Hematological Cancers Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Non-Hematological Cancers Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Non-Hematological Cancers Market Share (2019-2020)
Table 60. Southeast Asia Non-Hematological Cancers Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Non-Hematological Cancers Market Share by Type (2015-2020)
Table 62. Southeast Asia Non-Hematological Cancers Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Non-Hematological Cancers Market Share by Application (2015-2020)
Table 64. India Key Players Non-Hematological Cancers Revenue (2019-2020) (Million US$)
Table 65. India Key Players Non-Hematological Cancers Market Share (2019-2020)
Table 66. India Non-Hematological Cancers Market Size by Type (2015-2020) (Million US$)
Table 67. India Non-Hematological Cancers Market Share by Type (2015-2020)
Table 68. India Non-Hematological Cancers Market Size by Application (2015-2020) (Million US$)
Table 69. India Non-Hematological Cancers Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Non-Hematological Cancers Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Non-Hematological Cancers Market Share (2019-2020)
Table 72. Central & South America Non-Hematological Cancers Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Non-Hematological Cancers Market Share by Type (2015-2020)
Table 74. Central & South America Non-Hematological Cancers Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Non-Hematological Cancers Market Share by Application (2015-2020)
Table 76. Novartis Company Details
Table 77. Novartis Business Overview
Table 78. Novartis Product
Table 79. Novartis Revenue in Non-Hematological Cancers Business (2015-2020) (Million US$)
Table 80. Novartis Recent Development
Table 81. Pfizer Company Details
Table 82. Pfizer Business Overview
Table 83. Pfizer Product
Table 84. Pfizer Revenue in Non-Hematological Cancers Business (2015-2020) (Million US$)
Table 85. Pfizer Recent Development
Table 86. Bristol-Myers Squibb Company Details
Table 87. Bristol-Myers Squibb Business Overview
Table 88. Bristol-Myers Squibb Product
Table 89. Bristol-Myers Squibb Revenue in Non-Hematological Cancers Business (2015-2020) (Million US$)
Table 90. Bristol-Myers Squibb Recent Development
Table 91. Johnson & Johnson Company Details
Table 92. Johnson & Johnson Business Overview
Table 93. Johnson & Johnson Product
Table 94. Johnson & Johnson Revenue in Non-Hematological Cancers Business (2015-2020) (Million US$)
Table 95. Johnson & Johnson Recent Development
Table 96. Roche Company Details
Table 97. Roche Business Overview
Table 98. Roche Product
Table 99. Roche Revenue in Non-Hematological Cancers Business (2015-2020) (Million US$)
Table 100. Roche Recent Development
Table 101. Amgen Company Details
Table 102. Amgen Business Overview
Table 103. Amgen Product
Table 104. Amgen Revenue in Non-Hematological Cancers Business (2015-2020) (Million US$)
Table 105. Amgen Recent Development
Table 106. Astellas Pharma Company Details
Table 107. Astellas Pharma Business Overview
Table 108. Astellas Pharma Product
Table 109. Astellas Pharma Revenue in Non-Hematological Cancers Business (2015-2020) (Million US$)
Table 110. Astellas Pharma Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Non-Hematological Cancers Market Share by Type: 2020 VS 2026
Figure 2. Chemotherapy Features
Figure 3. Surgery Features
Figure 4. Radiation Therapy Features
Figure 5. Others Features
Figure 6. Global Non-Hematological Cancers Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Oncology Treatment Centre Case Studies
Figure 9. Ambulatory Surgery Centers Case Studies
Figure 10. Others Case Studies
Figure 11. Non-Hematological Cancers Report Years Considered
Figure 12. Global Non-Hematological Cancers Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Non-Hematological Cancers Market Share by Regions: 2020 VS 2026
Figure 14. Global Non-Hematological Cancers Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Non-Hematological Cancers Market Share by Players in 2019
Figure 17. Global Top Non-Hematological Cancers Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-Hematological Cancers as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Non-Hematological Cancers Revenue in 2019
Figure 19. North America Non-Hematological Cancers Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Non-Hematological Cancers Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Non-Hematological Cancers Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Non-Hematological Cancers Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Non-Hematological Cancers Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Non-Hematological Cancers Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Non-Hematological Cancers Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed

以下、関連資料のご紹介

非血液がん治療の世界市場（～2026年）

Global Non-Hematological Cancer Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04000 2020年11月20日 97Pages
当調査資料は非血液がん治療のグローバル市場について調査・分析したレポートです。種類別（化学療法、手術、放射線療法、その他）市場規模、用途別（病院、腫瘍治療センター、外来手術センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、...

血液悪性腫瘍の世界市場（～2026年）

Global Hematological Malignancies Market Size, Status and Forecast 2020-2026
MRC2-11QY12151 2020年11月25日 92Pages
当調査資料は血液悪性腫瘍のグローバル市場について調査・分析したレポートです。種類別（白血病、リンパ腫、骨髄腫）市場規模、用途別（病院薬局、医療店、Eコマースプラットフォーム）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、イン...

婦人科がんの世界市場（～2026年）

Global Gynecological Cancers Market Size, Status and Forecast 2020-2026
MRC2-11QY12079 2020年11月25日 96Pages
当調査資料は婦人科がんのグローバル市場について調査・分析したレポートです。種類別（化学療法、標的療法、ホルモン療法）市場規模、用途別（病院、クリニック、専門がん治療センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、イン...

血液悪性腫瘍性疾患の世界市場（～2026年）

Global Hematological Malignancies Disease Market Size, Status and Forecast 2020-2026
MRC2-11QY12150 2020年11月25日 125Pages
当調査資料は血液悪性腫瘍性疾患のグローバル市場について調査・分析したレポートです。種類別（化学療法、免疫療法、標的療法）市場規模、用途別（白血病、リンパ腫、骨髄腫）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オース...

血液疾患診断・治療の世界市場（～2026年）

Global Hematological Disorders Diagnostic and Therapeutic Market Size, Status and Forecast 2020-2026
MRC2-11QY12149 2020年11月25日 96Pages
当調査資料は血液疾患診断・治療のグローバル市場について調査・分析したレポートです。種類別（薬剤、物質）市場規模、用途別（病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メ...

ユビキチンプロテアソームの世界市場（～2026年）

Global Ubiquitin Proteasome Market Size, Status and Forecast 2020-2026
MRC2-11QY04917 2020年11月20日 95Pages
当調査資料はユビキチンプロテアソームのグローバル市場について調査・分析したレポートです。種類別（ベルケイド、キプロリス）市場規模、用途別（がん、神経変性疾患、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オー...

腫瘍栄養学の世界市場（～2026年）

Global Oncology Nutrition Market Size, Status and Forecast 2020-2026
MRC2-11QY04049 2020年11月20日 94Pages
当調査資料は腫瘍栄養学のグローバル市場について調査・分析したレポートです。種類別（頭頸部がん、胃がん、消化器がん、肝臓がん、膵臓がん、食道がん、肺がん、乳がん、血液がん、その他のがん）市場規模、用途別（クリニック、病院）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イ...

片頭痛の世界市場（～2026年）

Global Migraine Market Size, Status and Forecast 2020-2026
MRC2-11QY12691 2020年11月25日 94Pages
当調査資料は片頭痛のグローバル市場について調査・分析したレポートです。種類別（トリプタン、麦角）市場規模、用途別（病院、クリニック、在宅医療）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米...

イブルチニブの世界市場（～2026年）

Global Imbruvica Market Size, Status and Forecast 2020-2026
MRC2-11QY12307 2020年11月25日 91Pages
当調査資料はイブルチニブのグローバル市場について調査・分析したレポートです。種類別（5mg、10mg、140mg）市場規模、用途別（マントル細胞リンパ腫、慢性リンパ性白血病、ワルデンストレームマクログロブリン血症、再発/難治性辺縁帯リンパ腫、慢性移植片対宿主病）市場規模、地域別（北米、米国、カナダ、...

クラッベ病治療の世界市場（～2026年）

Global Krabbe Disease Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY12467 2020年11月25日 94Pages
当調査資料はクラッベ病治療のグローバル市場について調査・分析したレポートです。種類別（抗けいれん薬、筋弛緩薬、造血幹細胞移植、その他）市場規模、用途別（病院、ASC）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オー...

非血液がん治療の世界市場（～2026年） Non-Hematological cancers which cover lung cancer, prostate cancer, breast cancer and others, this type of cancer are not show easily diagnosis and the treatment process is also show long that some time it lead to the death of the patient. North America has the huge number of population suffering fr…
婦人科がんの世界市場（～2026年） Gynecological cancers are characterized by uncontrolled growth and spread of abnormal cells. The growth of the global gynecological cancer drugs market is driven by factors such as increase in incidence of gynecological cancers, growth in importance of targeted drug therapies, rise in investment fro…
血液悪性腫瘍の世界市場（～2026年） Hematologic malignancies are forms of cancer that begin in the cells of blood-forming tissue, such as the bone marrow, or in the cells of the immune system. Market Analysis and Insights: Global Hematological Malignancies Market The global Hematological Malignancies market size is projected to reach …
血液悪性腫瘍性疾患の世界市場（～2026年） Market Analysis and Insights: Global Hematological Malignancies Disease Market The global Hematological Malignancies Disease market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Hematological Malignancies Disease Scope and …
血液疾患診断・治療の世界市場（～2026年） Hematology, a branch of medicine, deals with the prevention, diagnosis, and treatment of blood diseases. It includes problems associated with red blood cells (RBCs), white blood cells (WBCs), platelets, bone marrow, blood vessels, spleen, lymph nodes, and proteins involved in bleeding and clotting p…